We review Acuity's Q1 2025 results ahead of the upcoming earnings. Click here to find out why AYI stock is a Hold.

The healthcare technology space is gaining enormous investors' attention these days, thanks to the rapid advancements in artificial intelligence (AI) in this niche. Companies like Tempus AI TEM are ...

As Trump’s trade war led stocks to post their worst first quarter since 2022, diversification proved its worth.

Against typical form, the U.S. Department of Agriculture’s March acreage and stocks data on Monday offered none of the ...

M&A deals succeed now instead of failing. This isn’t luck — but focused leadership and culture-building. Here is how firms ...

BMG achieved organic revenue growth of 8.1% in the 2024 financial year. The reported revenue growth was 6.4% to €963 million, ...

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market ...

Sartorius faces uncertainty with leadership changes and high debt levels. Read why DCF valuation models suggest SARTF stock ...

Shortstop has been a whirlwind of a position for the Pirates over the last few years. Primarily, the position revolved around ...

Berkshire Hathaway's cash balance is at an all-time high, a curious move considering how optimistic investors have been over ...

Pepsi stock is hovering around a four-year low as sales volumes dip across its core segments: PepsiCo Beverage, Frito-Lay, ...

Sei Foundation revealed plans to acquire genetic testing firm 23andMe, which filed for bankruptcy early this week.